Business Segments Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2025-01-23 5-day change 1st Jan Change
179,100.00 KRW -0.78% Intraday chart for Celltrion, Inc. -0.89% -4.48%

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (KRW)
Fiscal Period: December2014201520162017201820192020202120222023

Biological Products

          

Bio Medical Supply

982B 1,690B 1,616B 1,937B 1,873B

D&A

145B 163B 174B 175B 195B

Operating Income

360B 703B 712B 618B 638B

Pharmaceutical Products

          

Chemical Drugs

173B 242B 557B 654B 501B

D&A

13.63B 16.49B 46.13B 51.1B 53.81B

Operating Income

15.33B 8.53B 57.49B 34.61B 27.86B

Other

4.27B 2.63B 3.05B 3.88B 5.14B

D&A

520M 277M 281M 297M 240M

Operating Income

-1.12B 211M 224M 294M 454M

Intersectoral Insider Transaction Reconciliation

-30.36B -85.76B -264B -311B -203B

D&A

-372M -328M -320M -304M -3.1B

Operating Income

4.06B 599M -17.06B -5.3B -15.2B

Geographical Revenue Distribution History

Geographical breakdown of sales (KRW)
Fiscal Period: December2014201520162017201820192020202120222023

South Korea

1,017B 1,542B 2,015B 2,324B 2,262B

Total Assets

- - 2,160B 2,341B 14,258B

Interest Expense

- - - - -

Income Tax Expense

- - - - -

D&A

- - - - -

CAPEX

- - - - -

Net Income

- - - - -

EBT

- - - - -

Americas

- - 84.61B 131B 117B

Total Assets

- - 209M - -

Asia

- - 76.42B 140B -

Total Assets

- - 308B 300B 117B

Foreign

111B 308B - - -

Consolidation Adjustment

- - -264B -311B -203B

Total Assets

- - -5.98B -11.1B -22.06B

Total Assets

- - - - 185B

Total Assets

- - - - 3.48B

Total Assets

- - - - 1.72B

Total Assets

- - - - 7.91B